European Archives - Page 199 of 1216 - European Medical Journal

Vitiligo Treatment Breakthrough: Bacterial Therapy May Restore Pigmentation

A gut-derived bacterial compound significantly slows vitiligo progression in mice, offering new hope for treatment and repigmentation.

Smart Contact Lens Technology for Wearable Biosensors and Drug Delivery

There is a growing need for personalised medicine to manage and prevent diseases, as well as to monitor patient health continuously, even…

Polymer-Free versus Biodegradable Stents: New Insights into Safety and Efficacy

Polymer-free stents match biodegradable-polymer stents in PCI outcomes but pose a higher early thrombosis risk, requiring careful clinical consideration.

Black Males Overlooked in Prostate Cancer Clinical Trials

Black males have the highest incidence and mortality rates for prostate cancer in the USA, but their participation in clinical trials remains disproportionately low.

Air Pollution Drives Lung Cancer Mortality Despite Smoking Decline

New research reveals shifting patterns in lung cancer mortality, with declining smoking rates offset by rising deaths linked to air pollution.

New Imaging Technique Could Revolutionise Surgery for Hypertension

PET/CT imaging with gallium-68 (Ga-68) pentixafor can effectively guide surgery for patients with primary aldosteronism, according to recent study.

Engineered Heart Muscle Patch Transforms Heart Failure Treatment

Engineered heart muscle allografts safely remuscularize failing hearts, showing promise for heart failure treatment in primates and humans.

Shared Care Model for Hematopoietic Cell Transplantation Shows Promise

Shared care after HCT improves quality of life at day 100 without affecting survival, offering a viable post-transplant model.

New Equation May Improve Early Detection of Diabetic Nephropathy

Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area.

New Insights into Predicting Remission for Severe Asthma Using Mepolizumab

Early ACQ-5 score predicts mepolizumab treatment success in severe eosinophilic asthma, guiding clinical decisions.